CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 
Johnson & Johnson  (JNJ)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 
Price: $135.5350 $-1.35 -0.983%
Day's High: $ 137.43 Week Perf: 3.91 %
Day's Low: $ 135.51 30 Day Perf: 7.03 %
Volume (M): 1,220 52 Wk High: $ 148.32
Volume (M$): $ 165,939 52 Wk Avg: $ 132.38
Open: 137.00 52 Wk Low: 118.62
You need to upgrade your Flash Player


 Market Capitalization (Millions $) 368,831
 Shares Outstanding (Millions) 2,721
 Employees 126,500
 Revenues (TTM) (Millions $) 80,684
 Net Income (TTM) (Millions $) 1,372
 Cash Flow (TTM) (Millions $) 4,971
 Capital Exp. (TTM) (Millions $) 3,563
Johnson & Johnson
Johnson & Johnson, is engaged in the manufacture and sale of a broad range of products in the health care field. Through over 200 operating companies, it conducts business in virtually all countries of the world. Johnson & Johnson's primary interest, both historically and currently, has been in products related to human health and well-being. Johnson & Johnson was organized in the State of New Jersey in 1887.


JNJ is expected to report next financial results on October 15, 2018. Next quarterly dividend payout on September 10, 2018.
 

Johnson & Johnson's Segments
 
PROCRIT
 Segment    3.06 % of total Revenue
RISPERDAL
 Segment    2.82 % of total Revenue
REMICADE
 Segment    18.37 % of total Revenue
VELCADE
 Segment    3.84 % of total Revenue
CONCERTA
 Segment    2.42 % of total Revenue
INVEGA
 Segment    1.8 % of total Revenue
Other
 Segment    9.08 % of total Revenue
Total Pharmaceutical
 Segment    44.67 % of total Revenue
Med. Dev. & Diag.
 Segment    35.75 % of total Revenue
Nutritionals
 Segment    5.48 % of total Revenue
Skin Care
 Segment    5.03 % of total Revenue
Total Consumer
 Segment    19.58 % of total Revenue
 
  Company Estimates  
  Revenue Outlook
Johnson & Johnson does not provide revenue guidance.

Earnings Outlook
Johnson & Johnson issued annual earnings guidance on Oct. 13, 2015

 
Geographic Revenue Dispersion
United States 46.79 %
Europe 25.49 %
Asia Pacific 18.08 %
Other 9.63 %

Manhattan Scientifics Inc

Sales and Earnings Unchanged

In the second quarter Manhattan Scientifics Inc reached break-even of $0.00 per share compare to $0.00 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.04 millions in the same quarter a year ago and sequentially from $0.00 millions.

United Health Products, Inc.

Deficit Bigger Than a Year Ago, Topline Tumbles

United Health Products, Inc reported disastrous second quarter, where Sales faded to $0.00 millions and loss per share has widen to $-0.01, from the same quarter a year ago.

Auscrete Corp

Losses Widen but Revenues Unchanged

In the second quarter Auscrete Corp increased losses of $-0.07 per share compare to $-0.03 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Liberated Solutions, Inc.

Sales and Earnings Unchanged

In the third quarter Liberated Solutions, Inc reached break-even of $0.00 per share compare to $-0.01 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.05 millions in the same quarter a year ago and sequentially from $0.00 millions.

Vivos Inc

Vivos Inc announced second quarter operating deficit of $-0.3419 millions

In the second quarter Vivos Inc lost money of $-0.07 per share compare to $-0.13 a year ago and increased losses from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.01 millions in the same quarter a year ago and sequentially from $0.02 millions.




JNJ's Valuation Current
Price to Earnings PE Ratio (TTM) 260.23
Price to Earnings PE Ratio (Expected) 21.95
Price to Sales (TTM) 4.57
Price to Sales (Expected) -
Price to Book 5.86
PEG (TTM) -
JNJ's Financial Strength Current
Quick Ratio 0.97
Working Capital Ratio 2.42
Leverage Ratio (MRQ) 1.33
Total Debt to Equity 0.51
Interest Coverage (TTM) 25.48
Debt Coverage (TTM) 0.77
Per Share Current
Earnings (TTM) 0.52 $
Revenues (TTM) 29.65 $
Cash Flow (TTM) 1.83 $
Cash 6.67 $
Book Value 23.11 $
Dividend (TTM) 3.42 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
JNJ's Efficiency Current
Revenue per Employee (TTM) 637,818
Net Income per Employee (TTM) 10,846
Receivable Turnover Ratio (TTM) 5.88
Inventory Turnover Ratio (TTM) 3.07
Asset Turnover Ratio (TTM) 0.52
JNJ's Profitability Ratio Current
Gross Margin 66.75 %
Operating Margin 26.23 %
Net Margin 18.98 %
Net Cash Flow Margin 14.07 %
Effective Tax Rate (TTM) 92.29 %
Management Effectiveness Current
Return On Assets (TTM) 0.88 %
Return On Investment (TTM) 1.08 %
Return On Equity (TTM) 2.11 %
Dividend Yield 2.66 %
Payout Ratio (TTM) 656.66 %
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness


Customers Net Income fell by JNJ's customers Net margin fell to %
-5.3 % 3.38 %
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player


You need to upgrade your Flash Player

   
You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
     
MYL        0.6% 
CELG   -1.67%    
MRK        4.06% 
BMY        0.23% 
PFE        3.51% 
ABT        1.84% 
• View Complete Report
   


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SSNT's Profile

Stock Price

SSNT's Financials

Business Description

Fundamentals

Charts & Quotes

SSNT's News

Suppliers

SSNT's Competitors

Customers & Markets

Economic Indicators

SSNT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071